Well, we now know that 42 bipartisan members of the House were willing to act as PhRMA’s fax machines. I guess it shouldn’t have been a surprise — 80 House Dems signed a letter to Henry Waxman, telling him to substitute the White House PhRMA deal for his own much stronger language.
The question is, what are the Senate Democrats going to do about it?
| Fighting PhRMA | Owned by PhRMA | ||
| Script: “Thank Senator X for standing up to PhRMA and making biologic ‘drugs of the future’ available as generics on behalf of those with childhood diabetes, cancer and AIDS. Please keep fighting and bring this bill to the floor as Senate amendment.” | Script: “Will Senator X continue to do PhRMA’s bidding just like 42 Members of the House did and grant endless monopolies to drug companies on drugs developed with taxpayer dollars, or will they support Senator Brown’s amendment to make lifesaving biologic drugs available as affordable generics in my lifetime?” | ||
![]() |
Sherrod Brown (202) 224-2315 Web Form: brown.senate.gov/ Write on Sherrod Brown’s Facebook Wall Twitter Sherrod Brown |
Kay Hagan (202) 224-6342 Web Form: hagan.senate.gov/ Write on Kay Hagan’s Facebook Wall Twitter Kay Hagan |
|
![]() |
Chuck Schumer (202) 224-6542 Web Form: schumer.senate.gov/ Write on Chuck Schumer’s Facebook Wall Twitter Chuck Schumer |
![]() |
Orrin Hatch (202) 224-5251 Web Form: hatch.senate.gov/ Write on Orrin Hatch’s Facebook Wall Twitter Orrin Hatch |
![]() |
Debbie Stabenow (202) 224-4822 Web Form: stabenow.senate.gov/ Write on Debbie Stabenow’s Facebook Wall |
![]() |
Mike Enzi (202) 224-3424 Web Form: enzi.senate.gov/ Write on Mike Enzi’s Facebook Wall |
![]() |
Susan Collins (202) 224-2523 Web Form: collins.senate.gov/ Write on Susan Collins’ Facebook Wall Twitter Susan Collins |
||
![]() |
David Vitter (202) 224-4623 Web Form: vitter.senate.gov/ Write on David Vitter’s Facebook Wall Twitter David Vitter |
||
Eshoo’s Senate partner in patent pilfering is Kay Hagan. She offered up the same PhRMA-approved language that would give an “indefinite monopoly” (in the words of Henry Waxman) to PhRMA on lifesaving biologic drugs, which would prevent them from ever coming into generic form, also per Waxman. And we’re not talking about the difference between $10 and $50 here — we’re talking about $50,000 or $300,000 a year, costs that could forever put them out of affordability range even with insurance for most Americans, let alone third world country. Notably, if an AIDS vaccine ever came on the market, it would be a biologic.
There was a better Waxman-style alternative in the Senate, offered by Chuck Schumer and Sherrod Brown, which was defeated in the HELP Committee. Brown is now deciding whether to bring it to the floor as an amendment or not, which is why Anna Eshoo’s lovely picture graces a button on the top right side of this page. After yesterday’s article in the NY Times, I can think of 42 good reasons why he should.
So here’s the good guys and the bad guys. And yes, David Vitter IS a cosponsor of the Brown-Schumer biologics bill, so that tells you what a complete pile of shit the Eshoo-Hagan bill is. Give them a call and ask them what they plan to do about it.
After the shameful lesson of what happened with 42 members of the House, if we can’t do any better in the Senate — PhRMA really does pwn the entire country.










23 Comments








Support this site!
Subscribe to the newsletter
Advertise on Firedoglake
Send
us your tips
Make us your homepage
About FDL Action
But, without such incentives for Big Pharma, who will provide the billions of dollars of
funding for the high-risk research needed to discover such drugs?
Oh, never mind.
Orrin Hatch deleted my question on Facebook:
(or something approx. like it — boy they deleted it quickly!)
The Great Firewall of Utah.
And you didn’t even mention BCCI.
David Vitter didn’t delete me:
Yes, I really did just write the words “thank you Senator Vitter.” Who is, indisputably, better than Anna Eshoo and Kay Hagan on this issue that is of vital importance to women’s health.
And who could have guessed that! I would really like to know why he’s doing this. Fascinating.
Thanks, Jane, for the tremendous work you do every day.
Praise when merited, even if it is Vitter.
And scorn for those like Hagen. (I’d assume that Hatch is a lost cause from the beginning but nice try)
So there’s no way to pressure Reid et al to replace the Eshoo-like PhRMA-approved language with the Waxman-style alternative offered by Brown and Schumer now, before a merged bill goes to the Senate floor. Wasn’t clear on that. Thank you! Hagan won out in the HELP committee?
Vitter doesn’t look anywhere near 49 in the picture.
Well, maybe there’s some kind of magic youth formula in wearing diapers.
He’s not. He’s still in diapers, ya know.
Sounds like some pretty exotic drug. Isn’t the average prescription drug about $70?
Yep, that is the current crony capitalism answer.
The free market answer is “the shareholders”. That’s what risk is about. You would think the market fundamentalists would realize that.
I don’t believe for a minute any of these congress folk read their Facebook or Twitter pages. Bodies, bodies… go to their offices bearing signs and pictures of the dead and dying and stop taking out your checkbook for the DNC, OFA and any other political group pretending to help Americans.
Perhaps a bit OT, but I believe the primary argument being used by Pharma to prevent generic forms of biologics is that generic manufacturers cannot GUARANTEE that the generics will be exactly the same as the branded concoction. I have news for those who want to hear it. rDNA genetically-engineered insulin was the FIRST biotech drug to be marketed commercially (the fact that it is regulated as a small molecule drug I’ll leave for another debate). TO DATE, the insulin manufacturers THEMSELVES cannot guarantee (1) exactly what is in the vial of insulin (prions and other downstream garbage); or that the product is uniformly bio-identical from batch to batch. And this has been on the market for more than 20 years.
The biotech industry has now coined a term–bio-equivalence–which means the drug must react in the same manner as the original (branded) molecule, but in no way guarantees that it is exactly bio-identical. In fact, human insulin has been shown in scientific studies to actually be DIFFERENT than human insulin created within the human body. Two other bio-equivalent drugs that have horror stories associated with them (depending on the patient) are Synthroid and Premarin.
$Pharmaceutical$. Friend of mine went to the pharmacy yesterday for a refill of Advair (anti-asthmatic drug). Pharmacist told her: “You know this one medication sustains so many and for those without insurance it costs $270 per 1-month script.” My friend walked back to her car in tears, since her asthma is on the severe side and she knows what suffering from it is all about. I did a google and came up with this lovely insight into how the pharmaceutical company is scrambling to develop something even better to continue reaping the almost $6B they’ve made off Advair thus far since, in May 2010, it goes generic.
Most new drug research is being done by the big universities with money provided by the government, not big Pharma. Pharma spends far more money on advertising their drugs, and even more money on lobbying Congress, then they do on research. Most of their research is being done to make minor changes in drug molecular makeup before their patents expire and others can produce generics.
In the old days Pharma’s efforts at lobbying would have been called bribery, now it is just the way of life in Washington D.C.
Pharma’s gluttonous ways finally coming home to roost. I’ll bet many don’t know that many pharmaceuticals also own their generic ccounterparts and they control distribution. It’s criminal how a big drug maker who makes a generic turns off the machine, slaps a brand name label on and then feels OK about charging many times more the cost of the drug. I guess without that how would they make 20% profits. Ain’t Pharma grand!
Thank you, Jane.
And just to remind people, ‘shareholders’ of corporations (like Phrmas) do not need to be US citizens.
For all that we know, oiligarchs, drug lords, and offshore tax havens are buying up the stock and would reap the profits of these ‘permanent patents’.
Here’s your one word biologic answer:
Herceptin.
____
Also note in link above how Aussies have forced the Pharma that makes it to lower wholesale costs….something we gave up up here in Canada when we went all in with gouger…errrr….increased patent protection awhile back.
.
Thanks, Jane, for blowing the cover off America’s real War on Drugs, as Drugs’ War on America.
Interestingly, a pharmacist acquaintance of mine bragged that Advair and other asthma-related inhalants only cost them a fraction of the amount that they charge patients. “Best profit-maker in the store!” But get this, their best customers have Medicare, so guess who pays the bulk of the Advair bill? Well, it turns out to be the good old taxpayer, but you know the Republicans say that Medicare is going bankrupt. I wonder why? The entire system is corrupt, not only PhRma and the insurance companies, but also the medical and pharmaceutical industries. You really can’t isolate certain sectors like the Obama Admin tried and realistically expect cost containment to magically arise. I say kill the obscene PO travesty, pass the recision and pre-existing condition reforms and stock up for a long winter of attacking the conserva-Dems. I don’t think they can survive another bout from Jane and FDL. I think we could at least get a decent PO if we kept up the fight another year. If we give up now we are going to get a dog that won’t succeed in doing anything, let alone contain any costs.
You said it, and righteously so!
Wow, they are fast! Me too.